TrialClinical pharmacokinetics2019

Population Pharmacokinetics of Upadacitinib Using the Immediate-Release and Extended-Release Formulations in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I-III Clinical Trials.

Ben Klünder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.